🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to investigate if treatment with Ixazo...
Status
Completed
Location
Odense University Hospital
Start Date
2019-10-24
Trial ID
NCT04028115
Treatments Being Tested
This phase I trial studies the side effects and best dose of ixazomib when ...
Status
Completed
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2014-10-08
Trial ID
NCT02070458
Treatments Being Tested
The purpose of this phase 1/2, open-label study was to evaluate the effect ...
Status
Completed
Location
Multiple Locations
Start Date
2011-06-27
Trial ID
NCT01335685
Treatments Being Tested
The primary objective of this study is to determine the safety profile, tol...
Status
Completed
Location
Mayo Clinic- Scottsdale
Start Date
2009-10
Trial ID
NCT00963820
Treatments Being Tested
The purpose of this research study is to evaluate a treatment regimen calle...
Status
Active Not Recruiting
Location
City of Hope
Start Date
2015-01-20
Trial ID
NCT02253316
Treatments Being Tested
Single arm phase I/II study of ixazomib and romidepsin in relapsed/refracto...
Status
Terminated
Location
University of Illinois Cancer Center
Start Date
2018-09-26
Trial ID
NCT03547700
Treatments Being Tested
Patients with mantle cell lymphoma (MCL) that has relapsed (come back) or r...
Status
Completed
Location
Winship Cancer Institute of Emory University
Start Date
2018-08-13
Trial ID
NCT03323151
Allogeneic stem cell (allo SCT) transplantation for multiple myeloma is a p...
Status
Terminated
Location
University Hospital of Freiburg
Start Date
2023-03-03
Trial ID
NCT05675319
Treatments Being Tested
The goal of this clinical research study is to learn if ixazomib can preven...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2015-03-20
Trial ID
NCT02302846
Treatments Being Tested
This phase II trial studies how well ixazomib citrate, pomalidomide, dexame...
Status
Completed
Location
Mayo Clinic
Start Date
2017-07-24
Trial ID
NCT03202628